Insights
Filter By
All Topics
Advocacy
Affordability
Analytics
Biosimilars
Commercialization
COVID-19
Data
Distribution
Engagement
Legislation
Market access
Medication adherence
Medication therapy management
Oncology
Patient care
Patient support services
Policy
Product access
Regulatory
Reimbursement
Research
Specialty pharmacy
Technology
Third-party logistics
Sort By
Date (Newest to Oldest)
Date (Oldest to Newest)
Title (A-Z)
Title (Z-A)
Filter
Innomar Strategies
The value of Real-World Evidence in Canadian drug commercialization: Part 2
Innomar Strategies
April 2021
Manufacturers
Webinar: Utilizing Real World Evidence Across the Product Life Cycle
Innomar Strategies
June 2020
Improved Health Outcomes in Patients Receiving Health Case Management
Innomar Strategies
April 2017
Case Study: Discovering New Opportunities for Growth in a Niche Market
Innomar Strategies
April 2015
Nurse-led Health Case Management
Innomar Strategies
Explore More by Topic
Advocacy
Affordability
Analytics
Biosimilars
Commercialization
COVID-19
brand="Cencora" culture="EN" env="Development" tracker="False"
